{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:40:11Z","timestamp":1759009211557,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"crossref","award":["2016-I2M-1-013"],"award-info":[{"award-number":["2016-I2M-1-013"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jinf.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T22:17:16Z","timestamp":1534803436000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum level of IL-8 is associated with reversion of QuantiFERON-TB gold in-tube tests"],"prefix":"10.1016","volume":"78","author":[{"given":"Henan","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.08.010_bib0001","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0002","first-page":"125","article-title":"IGRA expert committee; centers for disease control and prevention (CDC). Update guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2013\u2013United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jinf.2018.08.010_bib0003","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0006","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","author":"Pai","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0007","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2018.08.010_bib0008","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2217\/fmb.11.82","article-title":"Redefining latent tuberculosis","volume":"6","author":"Sridhar","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jinf.2018.08.010_bib0009","doi-asserted-by":"crossref","first-page":"e54748","DOI":"10.1371\/journal.pone.0054748","article-title":"Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?","volume":"8","author":"Zwerling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.08.010_bib0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent tuberculosis: what are the sources of variability?","volume":"54","author":"Banaei","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2018.08.010_bib0011","unstructured":"ClinicalTrials.gov. A randomized, placebo controlled, partially blinded phase II study to evaluate safety, immunogenicity, and prevention of infection with Mycobacterium tuberculosis of AERAS-404 and BCG revaccination in healthy adolescents. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02075203."},{"key":"10.1016\/j.jinf.2018.08.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2018.04.009","article-title":"Predictive value of tuberculosis infection testing reversion for prophylactic treatment success: a systematic review and meta-analysis","author":"Zhang","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.08.010_bib0013","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0014","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1183\/09031936.00055508","article-title":"Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis","volume":"32","author":"Ruhwald","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2018.08.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.jinf.2018.08.010_bib0016","doi-asserted-by":"crossref","first-page":"e44944","DOI":"10.1371\/journal.pone.0044944","article-title":"Different patterns of cytokines and chemokines combined with IFN-\u03b3 production reflect mycobacterium tuberculosis infection and disease","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.08.010_bib0017","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","article-title":"Latent tuberculosis infection in rural China: baseline results of a population-based, multicenter, prospective cohort study","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0018","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1183\/13993003.00235-2016","article-title":"Annual risk of tuberculosis infection in rural China: a population-based prospective study","volume":"48","author":"Gao","year":"2016","journal-title":"Eur Respir J"},{"year":"2014","series-title":"Guidance of tuberculin skin test","author":"Cheng","key":"10.1016\/j.jinf.2018.08.010_bib0019"},{"key":"10.1016\/j.jinf.2018.08.010_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-11-245","article-title":"Specificity of a whole blood IGRA in German nursing students","volume":"11","author":"Schablon","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5588\/ijtld.11.0364","article-title":"Serial testing of Malaysian health care workers with QuantiFERON(R)-TB Gold In-Tube","volume":"16","author":"Rafiza","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0022","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.08.010_bib0023","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1152\/ajplung.00233.2002","article-title":"Pathophysiological roles of interleukin-8\/CXCL8 in pulmonary diseases","volume":"284","author":"Mukaida","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jinf.2018.08.010_bib0024","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/eji.1830220607","article-title":"Secretion of interleukin-8 following phagocytosis of mycobacterium tuberculosis by human monocyte cell lines","volume":"22","author":"Friedland","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jinf.2018.08.010_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI117702","article-title":"Enhanced interleukin-8 release and gene expression in macrophages after exposure to mycobacterium tuberculosis and its components","volume":"95","author":"Zhang","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jinf.2018.08.010_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/376559","article-title":"Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease","volume":"188","author":"Ma","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0028","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinthera.2012.03.006","article-title":"Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children","volume":"34","author":"Chiappini","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2018.08.010_bib0029","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2334-10-300","article-title":"Serial interferon-gamma release assays during treatment of active tuberculosis in young adults","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.08.010_bib0030","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2018.08.010_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinf.2017.04.011","article-title":"Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis","volume":"75","author":"Clifford","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.08.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148885","article-title":"Analysis of plasma cytokine and chemokine profiles in patients with and without tuberculosis by liquid array-based multiplexed immunoassays","volume":"11","author":"Xiong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.08.010_bib0033","doi-asserted-by":"crossref","first-page":"e51338","DOI":"10.1371\/journal.pone.0051338","article-title":"Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:27:14Z","timestamp":1759008434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344531830255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S016344531830255X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.08.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum level of IL-8 is associated with reversion of QuantiFERON-TB gold in-tube tests","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}